Healthcare Equipment and Supplies
Company Overview of Amedica Corporation
Amedica Corporation, a commercial biomaterial company, develops, manufactures, and sells various medical devices. The company offers Valeo family of silicon nitride interbody spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; Valeo stand-alone anterior lumbar intervertebral fusion device; and a line of non-silicon nitride spinal fusion products used by surgeons to promote bone growth and fusion in spinal fusion procedures. It also develops femoral heads for use in its total hip replacements; and femoral condyle components for use in its total knee replacements. The company markets and sells its products to surgeons and hospitals in the United States, Europe, ...
1885 West 2100 South
Salt Lake City, UT 84119
Founded in 1996
Key Executives for Amedica Corporation
Chief Executive Officer
Total Annual Compensation: $315.2K
Chief Financial Officer and Director
Total Annual Compensation: $150.0K
Chief Operating Officer
Total Annual Compensation: $191.4K
Chief Technology Officer
Total Annual Compensation: $228.5K
Compensation as of Fiscal Year 2013.
Amedica Corporation Key Developments
Amedica Corporation Announces Amendments to Articles of Incorporation or Bylaws
Feb 20 14
Effective as of February 19, 2014, Amedica Corporation amended and restated its bylaws in connection with the closing of the company’s initial public offering of shares of its common stock. The Board and the company's stockholders previously approved the Restated Bylaws to be in effect upon the closing of the company's initial public offering. The Restated Bylaws amend and restate in their entirety the company's bylaws to, among other things: (i) permit the board of directors to alter, amend or repeal the bylaws without obtaining stockholder approval; (ii) require the approval of at least 80% of the shares entitled to vote in the election of directors to adopt, amend or repeal the bylaws; (iii) require all stockholder actions be taken by a vote of the stockholders at an annual or special meeting and eliminate the ability of the stockholders to take any action by written consent in lieu of a meeting; (iv) set forth the requirements and procedures for calling a special stockholder meeting; (v) establish advance notice procedures for stockholder proposals relating to the nomination of candidates for election as directors or new business to be brought before any meeting of stockholders; (vi) establish a classified board of directors in which directors will be divided into three classes; (vii) provide for indemnification of the Company's directors, executive officers, other officers, employees and agents to the fullest extent permitted by the Delaware General Corporation Law; and (viii) designate the Court of Chancery of the State of Delaware to be the sole and exclusive forum for certain actions and proceedings. The Restated Bylaws may be amended upon the approval of holders at least 80% of the voting power of all then outstanding shares of capital stock entitled to vote in the election of directors, voting together as a single class, or, subject to certain limitations set forth therein, by the Board.
Amedica Corporation(NasdaqCM:AMDA) added to NASDAQ Composite Index
Feb 14 14
Amedica Corporation will be added to the NASDAQ Composite Index.
Amedica Corporation Appoints Jeff White to Board of Directors
Jan 23 14
Amedica Corporation announced the appointment of Jeff White to its Board of Directors. With more than 35 years of experience, Mr. White has been instrumental in the development and growth of various companies in the surgical device and biomaterial industry. Jeff is currently principal at Medtech Advisory Group LLC. Mr. White is a member of AOSpine and the International Society for the Advancement of Spine Surgery (ISASS).
Similar Private Companies By Industry
Recent Private Companies Transactions
August 30, 2013
Most Searched Private Companies
Sponsored Financial Commentaries